01-09-2016 | Original Article
CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated
Published in: Tumor Biology | Issue 9/2016
Login to get access